Effects of High- or Moderate-intensity Rosuvastatin on 1-year Major Adverse Cardiovascular Events Post-percutaneous Coronary Intervention
Morteza Chehrevar,
Reza Golchin Vafa,
Mohammadhossein Rahmani,
et al
Published:
Citation: Interventional Cardiology 2022;17:e20.